Literature DB >> 33221615

Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting.

Antonio Cuadrado1, Carmen Cobo2, Miguel Mateo3, Antonio J Blasco4, Joaquin Cabezas5, Susana Llerena1, José I Fortea1, Pablo Lázaro4, Javier Crespo1.   

Abstract

INTRODUCTION: Linkage to care for hepatitis C includes a new tool: teleconsultation. Micro-elimination in prison is a recommendation and is feasible. An economic evaluation of telemedicine for hepatitis C virus (HCV) treatment in prisons has not yet been performed. This study aimed to provide a cost-minimization analysis comparing two strategies of HCV treatment in a prison: telemedicine clinical practice (TCP) and the usual clinical practice (UCP).
METHODS: An observational cost-minimization study was carried out on a cohort of inmates who received anti-HCV treatment in El Dueso prison (May 2016-November 2017). A decision tree was constructed, incorporating different clinical profiles according to the severity of the disease, the results of diagnostic tests, and treatment outcomes as well as the costs of each profile. Satisfaction with telemedicine was evaluated through an 11-question questionnaire with a 5-point Likert scale.
RESULTS: Seventy-five inmates were treated and underwent TCP with a follow-up of one year. The average cost per patient with the TCP strategy was €1,172 (€1,151 direct costs). Had UCP been carried out, the cost would have been €1,687 (€1,630 direct). Telemedicine consultation practice produced savings of €516 (30.6%) per patient, with total savings of €38,677. The transfer costs from prison to hospital represented the most important saving item, accounting for 99.3% of the TCP-related savings. The questionnaire revealed high levels of satisfaction with TCP, with a median score of 5 in each question. Sustained virological response rates were 94.7% after the first treatment and 100% after retreatment of the four relapses.
CONCLUSION: Telemedicine consultation practice is a more efficient strategy than UCP, mainly due to the reduction of transfer costs while preserving effectiveness and user satisfaction.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cost-minimization; Hepatitis C; Prison; Teleconsulting; Telemedicine

Mesh:

Year:  2020        PMID: 33221615     DOI: 10.1016/j.drugpo.2020.103031

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  5 in total

Review 1.  Can Telemedicine Optimize the HCV Care Cascade in People Who Use Drugs? Features of an Innovative Decentralization Model and Comparison with Other Micro-Elimination Strategies.

Authors:  Riccardo Nevola; Valerio Rosato; Vincenza Conturso; Pasquale Perillo; Teresa Le Pera; Ferdinando Del Vecchio; Davide Mastrocinque; Annalisa Pappalardo; Simona Imbriani; Augusto Delle Femine; Alessia Piacevole; Ernesto Claar
Journal:  Biology (Basel)       Date:  2022-05-24

2.  Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.

Authors:  Hsu-Heng Yen; Pei-Yuan Su; I-L Ing Liu; Ya-Huei Zeng; Siou-Ping Huang; Yu-Chun Hsu; Po-Ke Hsu; Yang-Yuan Chen
Journal:  BMC Gastroenterol       Date:  2021-05-08       Impact factor: 3.067

3.  Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis.

Authors:  Hsu-Heng Yen; Yang-Yuan Chen; Jun-Hung Lai; Hung-Ming Chen; Chih-Ta Yao; Siou-Ping Huang; I-Ling Liu; Ya-Huei Zeng; Fang-Chi Yang; Fu-Yuan Siao; Mei-Wen Chen; Pei-Yuan Su
Journal:  J Clin Med       Date:  2022-03-27       Impact factor: 4.241

4.  Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences.

Authors:  Joaquin Cabezas; Susana Llerena; Miguel Mateo; Rocío Álvarez; Carmen Cobo; Victoria González; Elisa Martró; Antonio Cuadrado; Javier Crespo
Journal:  Diagnostics (Basel)       Date:  2021-05-14

Review 5.  Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination.

Authors:  Fátima Higuera-de la Tijera; Alfredo Servín-Caamaño; Luis Servín-Abad
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.